Age-associated B cells predict coronary events in humans and aggravate murine atherosclerosis
Cardiovascular Research · 24.09.2026 · 122 (13) · 1789-1802
DOI: 10.1093/cvr/cvag154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 13.07.2026. Verfasst von Jill de Mol und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands. Hauptthemen laut MEDLINE: B-Lymphocytes, Coronary Artery Disease, Aging, Atherosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Heart Foundation, Dutch Research Council, European Union.
Abstract (Originalsprache)
Aims
Aging is a major risk factor for cardiovascular disease (CVD) and is also linked to a functional decline of the immune system. B cells contribute to atherosclerosis progression by antibody secretion, antigen presentation and T-cell regulation. During aging, CD11c+CD21low B cells accumulate, but it is unclear whether these age-associated B cells (ABCs) are linked with incident cardiovascular events in humans and if they contribute to the progression of atherosclerosis. Methods and results To investigate associations with first-time coronary events (CEs), circulating B cells were phenotyped with flow cytometry in a case–control study (N = 604) nested in the Malmö Diet and Cancer study cohort with a median of 14 years follow-up. Splenic B cells in young (5 months) and aged (21 months) female Ldlr−/− mice were characterized with single-cell RNA-sequencing coupled with B-cell receptor (BCR)-sequencing. Atherogenicity of ABCs was determined by adoptive transfer to Ldlr−/− and Ldlr−/−Rag1−/− mice. Compared with other B-cell populations, ABCs showed a significant positive correlation with age (Spearman’s rho 0.24; P < 0.0001; across 46–68 years of age) and accumulated in aged atherosclerotic mice. CE cases had higher counts of ABCs than controls and regression analysis revealed an association with incident CEs, that was independent of cardiovascular risk factors [odds ratio: 1.92 (95% confidence interval 1.13–3.27), P = 0.016, comparing the fourth vs. first quartile]. Adoptive transfer of ABCs to recipient mice promoted atherosclerotic lesion development. In Ldlr−/− Rag1−/− mice, ABCs also increased necrotic cores (P < 0.05). B cells recovered from recipient mice after transfer expressed CD138 and secreted antibodies. In line with these findings, we demonstrated that ABCs expressed plasma cell (PC) differentiation genes and showed the greatest clonal expansion within the B-cell compartment, with extensive clonal overlap with PCs.
Conclusion
We show that ABCs predict first-time CEs in humans and contribute to the immunopathology of atherosclerosis in mice, indicating that clonal expansion and accumulation of ABCs contribute to the strong association between age and CVD. ABCs may serve as potential prognostic and therapeutic targets for CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, Leiden 2333CC, The Netherlands.
- Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
- Department of Medicine, LMU University Hospital, Munich, Germany.
- German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.
- Department of Translational Medicine, Lund University, Malmö, Sweden.
- Department of Internal Medicine, Skåne University Hospital, Lund, Sweden.
ORCID-Profile: Jill de Mol, Pernilla Katra, Alexandru Schiopu, Eva Bengtsson, Ilze Bot, Daniel Engelbertsen, Johan Kuiper, Harry Björkbacka, Amanda C Foks
Förderung
- Dutch Heart Foundation
- Dutch Research Council
- European Union
- Fondation Leducq Network of Excellence
- Swedish Research Council
- Swedish Heart Lung Foundation
- Albert Påhlsson Foundation
- Ministry of Research and Education of Romania
Zitieren
APA
de Mol, J., Katra, P., Smit, V., Witteveen, A., Tomas, L., Andersson, L., Engels, S. W. M., Andersson, S., Bernabé Kleijn, M. N. A., Schiopu, A., Bengtsson, E., Bot, I., Engelbertsen, D., Kuiper, J., Björkbacka, H., & Foks, A. C. (2026). Age-associated B cells predict coronary events in humans and aggravate murine atherosclerosis. Cardiovascular Research, 122(13), 1789-1802. https://doi.org/10.1093/cvr/cvag154
Vancouver
de Mol J, Katra P, Smit V, Witteveen A, Tomas L, Andersson L, et al. Age-associated B cells predict coronary events in humans and aggravate murine atherosclerosis. Cardiovascular Research. 2026;122(13):1789-1802. doi:10.1093/cvr/cvag154
BibTeX
@article{deMol2026,
author = {de Mol, Jill and Katra, Pernilla and Smit, Virginia and Witteveen, Anna and Tomas, Lukas and Andersson, Linda and Engels, Scott W M and Andersson, Samuel and Bernabé Kleijn, Mireia N A and Schiopu, Alexandru and Bengtsson, Eva and Bot, Ilze and Engelbertsen, Daniel and Kuiper, Johan and Björkbacka, Harry and Foks, Amanda C},
title = {Age-associated B cells predict coronary events in humans and aggravate murine atherosclerosis},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {13},
pages = {1789--1802},
doi = {10.1093/cvr/cvag154}
}
EUVIMED